Zydus Lifesciences Limited has informed the Exchange regarding a press release dated March 04, 2025, titled "Zydus, supported by the Gates Foundation, to develop the world s first combination vaccine to offer protection against shigellosis and typhoid for infants and children".
Press Release Mar 04 2025
Filed with NSE · · 3 pages · English
Summary by 6ix AI
Zydus Lifesciences Limited has announced a press release regarding the development of a combination vaccine for shigellosis and typhoid, aimed at infants and children, supported by the Gates Foundation. This initiative highlights India's innovation capabilities in addressing critical public health issues related to enteric diseases. The project will involve early-stage development and regulatory studies, with collaboration for research and co-development of the vaccine. Dr. Sharvil Patel, Managing Director, emphasized the commitment to providing affordable vaccines to improve global public health.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Release
Zydus Lifesciences Limited on 6ix
Earlier from Zydus Lifesciences
- Press Release Feb 26 2025
- Press Release Feb 22 2025
- Press Release Feb 14 2025
- Press Release Feb 12 2025
- Press Release Feb 05 2025
Later from Zydus Lifesciences
- Press Release Mar 05 2025
- Press Release Mar 10 2025
- Press Release Mar 12 2025
- Press Release Mar 14 2025
- Press Release Mar 16 2025
Follow Zydus Lifesciences into a list and get an email when it puts out news.
Follow Zydus Lifesciences